A study led by UT Southwestern Medical Center researchers has found that certain antibodies inhibit Mycobacterium ...

Researchers create nanomachines using metal and polyphenols, which enhance targeted intracellular delivery of antibodies for cancer therapy. Antibodies are Y-shaped proteins produced by the body’s ...

CSL has gotten the Memo about the value of recombinant polyclonal immunoglobulin (IgG) antibodies.  | The deal allows CSL to ...

Explore the latest advancements in bispecific antibodies for multiple myeloma, focusing on early treatment opportunities and innovative trial designs.

Monoclonal antibodies (mAbs) have been a key therapeutic option for non-communicable diseases for decades, and a small number of mAbs have helped treat infectious diseases, including COVID-19. The ...

Discover how Catalent's Rapid Antibody platform delivers GMP drug substance in 8 months, accelerating mAb development from gene construct to IND readiness.

A rare but serious clotting disorder linked to certain COVID-19 vaccines and natural adenovirus infections has puzzled scientists for years.

From penetrating solid tumors to new success rates for de novo design, the next wave of antibody therapies aims to transform the clinic.